/ZYME

Zymeworks Inc

ZYME

$26.24USD↓-0.74%-0.20 today

MARKET CAP

2.0B

P/E (TTM)

—

FWD P/E

7.8x

DAY RANGE

$26 – $27

52W RANGE

$15

$31

AI Summary

Stalk

StalkMedium

After a sharp markup and subsequent peak above the fast EMAs, ZYME has pulled back into a support confluence around the 9 EMA, 20 EMA, and 50 SMA. The medium-term bias remains bullish within a broader long-term uptrend, but short-term momentum is negative as price trades below the fast EMAs and the RSI has rolled over. Execution should be deferred, stalking for stabilization at the EMA/SMA zone before initiating a position. Key risks include a breakdown below the 50 SMA and 200 DMA that would shift the medium-term structure.

↑Xanadatamab PDUFA on Aug 25, 2026 could yield $250M milestone payment
↑Phase 1 ZW191 data show 68% response rate in heavily pre-treated ovarian patients
↓Negative earnings yield and net loss of $44.2M in Q1 2026 hinder returns

Full analysis →

Buying

4

institutions

Selling

6

institutions

New Positions

1

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	SELL	4.25 M	111.12 M	+-302.86 K	-2.5%	0.00%
PA Perceptive Advisors LLC Q2 2026	SELL	4.18 M	109.34 M	+-2.84 M	-37.8%	1.65%
CA Citadel Advisors LLC Q2 2026	SELL	966.34 K	25.26 M	+-284.18 K	-19.3%	0.00%
MG Man Group Plc Q2 2026	BUY	210.78 K	5.51 M	+20.89 K	+15.9%	0.01%
AC Aqr Capital Management LLC Q2 2026	BUY	111.28 K	2.91 M	+20.61 K	+28.1%	0.00%
JC Jpmorgan Chase & Co Q2 2026	SELL	106.40 K	2.56 M	+-7.67 K	-7.2%	0.00%
FA Fisher Asset Management, LLC Q2 2026	SELL	70.78 K	1.85 M	+-30.66 K	-27.2%	0.00%
JH Janus Henderson Group Plc Q1 2026	BUY	36.40 K	911.64 K	+18.20 K	+90.3%	0.00%
BH Brevan Howard Capital Management LP Q2 2026	BUYNEW	25.96 K	678.49 K	+25.96 K	+0.0%	0.01%
MM Millennium Management LLC Q2 2026	SELL	0.00	0.00	+-50.00 K	-100.0%	0.00%